Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy

Tsukasa Shimauchi; Ken Yamaura; Sayaka Sugibe; Sumio Hoka

doi:10.1016/j.aat.2014.02.005

Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy

Tsukasa Shimauchi, Ken Yamaura, Sayaka Sugibe, Sumio Hoka

研究成果: Contribution to journal › Article › 査読

4 被引用数 (Scopus)

抄録

A 54-year-old patient with Becker muscular dystrophy and dilated cardiomyopathy underwent laparoscopic cholecystectomy under total intravenous anesthesia. Muscle relaxation was induced by rocuronium (0.4 mg/kg body weight) under train-of-four (TOF) ratio monitoring. The TOF ratio was 0 at intubation, and 0.2 at the end of surgery. Residual muscle relaxant activity was successfully reversed by sugammadex (2 mg/kg body weight) without any hemodynamic adverse effects (TOF ratio 1.0 at extubation). The clinical and hemodynamic findings suggest that sugammadex can be safely used in patients with Becker muscular dystrophy and dilated cardiomyopathy.

本文言語	英語
ページ（範囲）	146-148
ページ数	3
ジャーナル	Acta Anaesthesiologica Taiwanica
巻	52
号	3
DOI	https://doi.org/10.1016/j.aat.2014.02.005
出版ステータス	出版済み - 9 1 2014

All Science Journal Classification (ASJC) codes

Anesthesiology and Pain Medicine

文献へのアクセス

10.1016/j.aat.2014.02.005

フィンガープリント「Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

@article{554e7cb8add645e2b96fa691cb918201,

title = "Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy",

abstract = "A 54-year-old patient with Becker muscular dystrophy and dilated cardiomyopathy underwent laparoscopic cholecystectomy under total intravenous anesthesia. Muscle relaxation was induced by rocuronium (0.4 mg/kg body weight) under train-of-four (TOF) ratio monitoring. The TOF ratio was 0 at intubation, and 0.2 at the end of surgery. Residual muscle relaxant activity was successfully reversed by sugammadex (2 mg/kg body weight) without any hemodynamic adverse effects (TOF ratio 1.0 at extubation). The clinical and hemodynamic findings suggest that sugammadex can be safely used in patients with Becker muscular dystrophy and dilated cardiomyopathy.",

author = "Tsukasa Shimauchi and Ken Yamaura and Sayaka Sugibe and Sumio Hoka",

note = "Publisher Copyright: Copyright {\textcopyright} 2014, Taiwan Society of Anesthesiologists. Published by Elsevier Taiwan LLC. All rights reserved. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",

year = "2014",

month = sep,

day = "1",

doi = "10.1016/j.aat.2014.02.005",

language = "English",

volume = "52",

pages = "146--148",

journal = "Asian Journal of Anesthesiology",

issn = "2468-824X",

publisher = "Elsevier Taiwan LLC",

number = "3",

}

TY - JOUR

T1 - Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy

AU - Shimauchi, Tsukasa

AU - Yamaura, Ken

AU - Sugibe, Sayaka

AU - Hoka, Sumio

PY - 2014/9/1

Y1 - 2014/9/1

N2 - A 54-year-old patient with Becker muscular dystrophy and dilated cardiomyopathy underwent laparoscopic cholecystectomy under total intravenous anesthesia. Muscle relaxation was induced by rocuronium (0.4 mg/kg body weight) under train-of-four (TOF) ratio monitoring. The TOF ratio was 0 at intubation, and 0.2 at the end of surgery. Residual muscle relaxant activity was successfully reversed by sugammadex (2 mg/kg body weight) without any hemodynamic adverse effects (TOF ratio 1.0 at extubation). The clinical and hemodynamic findings suggest that sugammadex can be safely used in patients with Becker muscular dystrophy and dilated cardiomyopathy.

AB - A 54-year-old patient with Becker muscular dystrophy and dilated cardiomyopathy underwent laparoscopic cholecystectomy under total intravenous anesthesia. Muscle relaxation was induced by rocuronium (0.4 mg/kg body weight) under train-of-four (TOF) ratio monitoring. The TOF ratio was 0 at intubation, and 0.2 at the end of surgery. Residual muscle relaxant activity was successfully reversed by sugammadex (2 mg/kg body weight) without any hemodynamic adverse effects (TOF ratio 1.0 at extubation). The clinical and hemodynamic findings suggest that sugammadex can be safely used in patients with Becker muscular dystrophy and dilated cardiomyopathy.

UR - http://www.scopus.com/inward/record.url?scp=84908151235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908151235&partnerID=8YFLogxK

U2 - 10.1016/j.aat.2014.02.005

DO - 10.1016/j.aat.2014.02.005

M3 - Article

C2 - 25199695

AN - SCOPUS:84908151235

VL - 52

SP - 146

EP - 148

JO - Asian Journal of Anesthesiology

JF - Asian Journal of Anesthesiology

SN - 2468-824X

IS - 3

ER -